Establishment of Blood Glucose Monitoring System Using the Internet

DOI PDF 被引用文献2件
  • Hyuk-Sang Kwon
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Jae-Hyoung Cho
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Hee-Soo Kim
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Bok-Re Song
    College of Nursing, The Catholic University of Korea, Seoul, Korea
  • Seung-Hyun Ko
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Jung-Min Lee
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Sung-Rae Kim
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Sang-Ah Chang
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Hee-Seung Kim
    College of Nursing, The Catholic University of Korea, Seoul, Korea
  • Bong-Yun Cha
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Kwang-Woo Lee
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Ho-Young Son
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • Jin-Hee Lee
    Department of Preventive Medicine, The Catholic University of Korea, Seoul, Korea
  • Won-Chul Lee
    Department of Preventive Medicine, The Catholic University of Korea, Seoul, Korea
  • Kun-Ho Yoon
    Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea

抄録

<jats:p>OBJECTIVE—The Internet is used worldwide as a communication tool. To improve the quality of diabetes control, we investigated the effectiveness of an Internet-based blood glucose monitoring system (IBGMS) on controlling the changes in HbA1c levels.</jats:p> <jats:p>RESEARCH DESIGN AND METHODS—We conducted a randomized clinical trial involving 110 patients who visited the outpatient clinic at the Kangnam St. Mary’s Hospital for 3 months. The study subjects were treated with IBGMS for 12 weeks, and the control group received the usual outpatient management over the same period. HbA1c and other laboratory tests were performed twice, once at the beginning of the study and again at the end of the study.</jats:p> <jats:p>RESULTS—The test results from the beginning of the study established that there were no significant differences between the two groups with respect to age, sex, diabetes duration, BMI, blood pressure, HbA1c, and other laboratory data. On follow-up examination 12 weeks later, HbA1c levels were significantly decreased from 7.59 to 6.94% within the intervention group (P &lt; 0.001). At the end of the study, HbA1c levels in the intervention group were significantly lower than in the control group after adjusting the baseline HbA1c (6.94 vs. 7.62%; P &lt; 0.001, respectively). Among patients with baseline HbA1c &lt;7.0%, the patients in the intervention group had lower HbA1c than those in the control group (6.38 vs. 6.99%; P &lt; 0.05). Among the patients with a baseline HbA1c ≥7.0%, the difference between the two groups appeared more obvious: HbA1c levels at the end of the study were 8.12%.</jats:p> <jats:p>CONCLUSIONS—This new IBGMS resulted in a significant reduction of HbA1c during the study period. We propose that this IBGMS be used as a method for improving diabetes control.</jats:p>

収録刊行物

  • Diabetes Care

    Diabetes Care 27 (2), 478-483, 2004-02-01

    American Diabetes Association

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ